The city of Boca Raton, Florida, currently has 1 active clinical trials seeking participants for Pancreatic Cancer research studies.
Study of Effect of Azeliragon in Patients Refractory to First-Line Metastatic Pancreatic Cancer
Recruiting
This is an open label study to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients refractory to first-line or second-line treatment of metastatic pancreatic cancer.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
10/09/2023
Locations: Boca Raton Regional Hospital, Lynn Cancer Institute, Boca Raton, Florida
Conditions: Metastatic Pancreatic Cancer